Since several sPLA2s have the capacity to generate modified LDL with a pro-atherogenic potential in vitro (154–157), it is tempting to speculate that LPA produced in LDL by these sPLA2s may contribute to the development of atherosclerosis through activating aortic mast cells. Here, PLA2G2D is linked to atherosclerosis.